Clinical Trials Browser

Completed × INDUSTRY × avelumab × Clear all

Stomach Neoplasms

Urothelial Cancer

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Merkel Cell

Ovarian Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

Carcinoma, Merkel Cell

Metastatic Solid Tumors

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Diseases, Ovarian Neoplasms

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis, Neoplasms, Recurrence

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

Ovarian Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Neoplasm Metastasis, Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung

Malignant Solid Tumour

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Recurrence, Stomach Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Clinical Trials

GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer

A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

JAVELIN Renal 101

Study of Avelumab-M3814 Combinations

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

Avelumab in First-line NSCLC (JAVELIN Lung 100)

AVENANCE

MERKLIN2

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

JAVELIN Bladder 100

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Phase I/Ib Multiple Ascending Dose Study in China

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

PAVE-1

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

JAVELIN Ovarian 200

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

CLASSICAL-Lung

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

JAVELIN Renal 100

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer